Clinical reviewer: Dr. Sarah Boss, MD

This guide is published by COGNIFUL, part of THE BALANCE GROUP. It compares selected international medical and residential pathways, including our program in Mallorca, Spain. It is not an independent league table. The providers below have different purposes and admission requirements; inclusion does not mean that each offers equivalent luxury accommodation or accepts every prescription-medication problem. COGNIFUL in Mallorca, Spain, offers detoxification as part of its addiction treatment pathway. Clinical assessment determines the appropriate care plan and setting. In some cases, treatment may begin with an initial 1–3 days in a partner hospital for observation and stabilization before continuing at COGNIFUL. The pathway is planned around each person’s medical needs. [1] [2]

Physical dependence describes adaptation to a medicine. Addiction involves a harmful pattern with impaired control, such as repeatedly taking more than intended despite consequences. These can overlap, but they are not interchangeable. Someone who takes a benzodiazepine exactly as prescribed may develop dependence and need help changing treatment without having a substance use disorder. The joint benzodiazepine guideline explicitly separates these situations. [3]

The starting question is therefore broader than whether a prescription is legal. What was it intended to treat? Is it still helping? What happens between doses? Has the person obtained additional supplies, hidden use, experienced overdose, or struggled to follow agreed limits? A useful assessment also takes pain, anxiety, insomnia, attention difficulties and other legitimate treatment needs seriously. Removing a medicine without addressing the problem it was treating can leave a major gap in care.

Bring an accurate account rather than a polished medication list. Include the product, formulation, prescribed instructions, actual use, recent changes and any nonprescribed supply. Explain alcohol use and other sedatives even if these seem unrelated. Different clinicians may hold different parts of the history. With your consent, one responsible professional should reconcile that information before a residential program promises a solution. A paid booking does not itself transfer prescribing responsibility. [2]

The table provides a starting shortlist, not a verdict about who is best for a particular person. Hospital-based medication assessment may be the priority when several illnesses or prescriptions interact. A structured addiction program may be more relevant when use has become difficult to control. Residential psychotherapy can become useful when immediate medical needs are stable and the person needs time to work on routines, relationships and the circumstances surrounding use.

Ask each provider to explain the proposed sequence in ordinary language. An answer should identify the first clinician, the setting for any withdrawal management, the treatment that follows and the professional who will continue prescriptions afterward. If the response consists mainly of a fixed stay length and a list of amenities, the clinical comparison is still incomplete. Also clarify whether the quoted service belongs to the named campus rather than another branch of the same organization.

Opioid pain medicines

Prescription opioids raise two connected questions: how to treat pain safely and whether opioid use disorder is present. For a diagnosed opioid use disorder, the CDC advises medication treatment and warns against detoxification alone because of increased risks of return to use and overdose. A program should be able to explain how it provides or arranges appropriate treatment, rather than making an empty medication list a universal recovery goal. [8]

For an international stay, establish continuity before travel. The receiving service needs to understand the existing treatment, and the clinician at home needs to know what they are being asked to continue. Do not assume the same product, formulation or prescribing arrangement will be available in every destination. These are questions for the relevant clinicians and dispensing services. A residential therapy plan should coexist with appropriate pain or addiction medication when clinically indicated.

Benzodiazepines and sleeping medicines

Benzodiazepines require particular care because abrupt stopping or overly rapid reductions can cause severe withdrawal, including seizures. Combining them with alcohol or opioid medication also raises serious safety concerns. The FDA warning supports a careful individual review; it does not mean every person using these medicines has an addiction or should enter residential rehab. [9]

Ask how the team will distinguish withdrawal symptoms from the return of anxiety or insomnia. A person may need an extended prescriber-led plan that continues beyond a residential stay. For persistent insomnia, ask about evidence-based sleep treatment, including cognitive behavioral therapy for insomnia, and whether an appropriate practitioner is actually involved. General relaxation sessions do not establish a specialist insomnia service. [10]

Stimulants and other prescriptions

When stimulant use has become harmful, an assessment should examine mental state, cardiovascular concerns, sleep and the pattern of use. Specialist guidance treats stimulant intoxication and withdrawal as their own clinical problems, not as variations of an alcohol detox package. The treatment plan should distinguish a prescribed medicine used appropriately from a substance use disorder, while considering the condition for which it was originally prescribed. [11]

Other medication concerns may primarily require a careful review, not addiction rehabilitation. For example, antidepressant withdrawal should not automatically be labeled addiction. COGNIFUL’s prescription-medication information makes this distinction and asks for the original indication, actual use and wider health history. A trustworthy service is willing to recommend a different pathway when residential treatment is not the right answer. [1]

Look for a coherent formulation: an explanation of how the medication, symptoms, behavior and environment fit together. This is more useful than simply collecting diagnoses. If someone uses pain medication to cope with both pain and emotional distress, those needs should be discussed together. If repeated early refills follow demanding travel or work schedules, the practical pattern should become part of treatment rather than disappearing once the person arrives at a residence.

Therapy should have identifiable goals. Possible goals include communicating honestly with prescribers, responding differently to cravings, rebuilding daily functioning, addressing shame or conflict, and preparing for predictable high-risk situations. The exact approach depends on assessment. Ask who delivers it, how the work is reviewed and what happens when a proposed intervention does not help. A long menu of methods is not a substitute for an explanation of why particular work is appropriate.

Family involvement can clarify the effects of medication use without making relatives responsible for clinical decisions. A family may have noticed sedation, missing appointments or changes in behavior. The person receiving care may describe pain or panic that relatives have not understood. With agreed consent and boundaries, treatment can bring those accounts together. Paying for care does not automatically give a relative access to every clinical detail, and a family conversation should not turn into an improvised prescribing consultation.

International treatment can offer distance from familiar pressures, but it also creates an additional handover. Before choosing a destination, ask whether travel is clinically appropriate now and whether any medical stabilization should happen closer to home. A person at risk of complicated withdrawal should not delay necessary care while searching for a preferred climate or suite. Severe confusion, seizure, breathing difficulty, suspected overdose or immediate danger needs urgent local medical help. [9]

Compare the whole route: departure, admission, any external medical care, discharge and return. Who holds the current medicine list at each stage? How will records be shared securely? Which language will clinical discussions use? Who is available if the return date changes? The answers should be specific enough to show that responsibility passes between professionals rather than being left to the client to reconstruct.

Practical privacy also changes across borders. Decide which family member or assistant may handle travel and invoices, which clinician may receive records, and what an employer actually needs to know. These are separate permissions. A personal assistant can organize logistics without becoming the clinical decision maker. Ask providers how they document consent, communicate changes and protect consultation time from business demands that might otherwise continue throughout the stay.

COGNIFUL offers a residential setting in Mallorca for people whose assessed needs can be met there. Its prescription-medication pathway considers dependence, problematic use and the medical care that may be required. A benzodiazepine or sleeping-medication concern does not automatically establish admission suitability. The clinical conversation should first determine whether a medication review, specialist withdrawal service, acute care or residential treatment is the appropriate next step. [1]

The residence accommodates a maximum of four clients at any time, each with a private suite. Clinical and bodywork sessions are individual. The residence, chef, personal manager, other holistic sessions, excursions and activities are shared. This format may appeal to someone who wants personal clinical conversations alongside a small shared living environment. It does not mean exclusive use of the property, a dedicated team for one person, a specified staffing ratio or a proven outcome advantage. [7]

For prescription-medication treatment, the practical discussion should go beyond whether the setting feels comfortable. Ask who will hold the medical overview, whether specialist input is required, how prescriptions will be managed and what happens if symptoms indicate that a different level of care is necessary. Any essential pain, sleep or addiction expertise should be confirmed in the individual proposal. Do not infer a particular prescribing service, hospital capability or overnight clinical arrangement from a description of personalized care. [2]

COGNIFUL Premier and Premier Plus both include assessment, an individual plan and continuing-care planning. Plus adds individual therapeutic work, additional family and transition work, and three months of aftercare. Base-program follow-up is agreed individually. The usual residential range is four to twelve weeks, reviewed for the individual. The published residential fees and usual stay range do not predict how quickly a medicine can be reduced or how long recovery will take. [7] View program fees

When comparing the two programs, identify the extra work that would matter in your situation. A complicated return to several prescribers, unresolved family communication or a difficult transition home may create specific planning needs. Ask what sessions, responsibilities and follow-up arrangements the proposal includes. The more expensive option should be considered through those concrete needs; a higher fee alone does not establish a better clinical match.

Both options require a written proposal confirming duration, inclusions, total fees and possible additional costs. COGNIFUL is generally self-pay and does not bill insurers directly. Documentation may support a reimbursement request, but reimbursement is not guaranteed. External medical treatment, travel and ongoing prescribing should be clarified separately. The final decision should leave you able to describe both the residential work and the medical arrangements that support it. [7]

A weekly residential price is only one part of a prescription-medication plan. Request a breakdown of assessment, medical withdrawal care if needed, the residential stay, additional specialist appointments, medication, travel and follow-up. Ask whether these are included, separately billed or arranged with another organization. Keep the scope of each quotation visible so that a hospital assessment is not compared with a longer residential program as if they were interchangeable purchases.

Also ask how changes are handled. If the clinical recommendation becomes longer or shorter, when is the cost reviewed? If the program cannot safely meet a newly identified need, what happens to the booking and the next referral? Clear answers help a family make a realistic financial decision without allowing the amount already paid to determine medical timing. Do not treat a prepaid package as a deadline for completing withdrawal.

Before discharge, identify a named clinician who has accepted responsibility for any continuing prescriptions. Confirm appointments rather than relying on a list of recommended providers. The handover should explain the medication history, relevant decisions, unresolved questions and the agreed response to deterioration. COGNIFUL’s continuing-care information emphasizes preparation for home and individually confirmed arrangements; it does not establish universal cross-border prescribing or telehealth availability. [12]

Build the everyday plan around the circumstances that contributed to difficulty. This might include a single agreed route for prescription questions, a plan for work travel, boundaries around medication requests from several clinicians, or family communication that avoids secrecy and surveillance. These practical arrangements support clinical treatment. They should be created with the person, not imposed as a punishment for having developed dependence or an addiction.

Ask each shortlisted service to answer the same three practical questions. What clinical problem do you believe you would be treating? Which parts of that problem can your own team manage, and which require another provider? What has to be in place for a safe discharge? Record the answers beside the proposed program rather than relying on an overall impression from an admissions call. Where answers conflict, take the written proposals back to an independent treating clinician who understands your history.

Does taking medication every day mean I need rehab?

No. Daily use may be appropriate, and physical dependence does not by itself establish addiction. The relevant questions concern benefit, harm, actual use, control and what support is needed for any change. Start with an assessment that can recommend ordinary medical review or outpatient care when those are sufficient. [1]

Is a residential stay long enough to finish a benzodiazepine taper?

There is no universal answer. Some clinician-led changes take substantially longer than a residential program. The joint guideline recognizes that timing must be individualized. Choose a service that can explain continuity beyond discharge, rather than one that promises a standard completion date before reviewing your history. [3]

Should opioid addiction treatment aim to stop all medication?

Not automatically. Evidence-based medication for opioid use disorder can be a central part of treatment. Detoxification alone is not recommended for that disorder. Ask how a program provides or arranges appropriate medication and how it will continue after any residential phase. [8]

Can COGNIFUL provide medical detox when I arrive?

Do not assume so. COGNIFUL in Mallorca, Spain, offers detoxification as part of its addiction treatment pathway. Withdrawal risk and other medical requirements are reviewed before admission, and appropriate medical care may be needed first. Do not stop a prescription in preparation for a stay. [2]

If prescription use has become worrying, you can contact COGNIFUL admissions to discuss clinical suitability, the residential format and the records needed for assessment. Explain the actual medicines and your current care arrangements. The useful outcome of that conversation is a clear, appropriate pathway, whether that begins with residential treatment or another medical service. [7]

1. Prescription medication concerns and residential treatment — COGNIFUL.
2. Clinical scope, suitability and care coordination — COGNIFUL.
3. Joint Clinical Practice Guideline on Benzodiazepine Tapering — American Society of Addiction Medicine and partner societies.
4. Psychiatry and Clinical Psychology Department — Clínica Universidad de Navarra.
5. Priory Hospital Roehampton — Priory.
6. Addiction and mental health services in Center City — Hazelden Betty Ford Foundation.
7. COGNIFUL programs, fees, admissions and suitability — COGNIFUL.
8. Opioid use disorder: treating — Centers for Disease Control and Prevention.
9. Benzodiazepine safety communication — US Food and Drug Administration.
10. Insomnia treatment — National Heart, Lung, and Blood Institute.
11. Clinical Practice Guideline on the Management of Stimulant Use Disorder — American Society of Addiction Medicine and American Academy of Addiction Psychiatry.
12. Reintegration and continuing care — COGNIFUL.

Primary clinical and provider pages accessed October 18, 2026. Individual services, admission and fees should be confirmed directly.